GlassScriptPhysician profile
Lisa L Lowe
NPI 1437121811
$1,232.96
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $355 · 2021: $357 · 2022: $96.13 · 2023: $21.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $21.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $21.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $211.41 | 2021-2022 | |
| Neos Therapeutics, LP | $164.87 | 2019-2020 | |
| Glaxosmithkline, LLC. | $141.66 | 2019-2021 | |
| Tris Pharma INC | $122.84 | 2019-2021 | |
| Kaleo, INC. | $109.22 | 2019-2021 | |
| Abbvie INC. | $53.53 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.86 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $39.62 | 2019 | |
| Merck Sharp & Dohme LLC | $31.24 | 2019-2021 | |
| Adlon Therapeutics L.P. | $29.60 | 2021 | |
| Sobi, INC | $28.32 | 2019-2020 | |
| Cranial Technologies, INC | $27.86 | 2019-2020 | |
| Pfizer INC. | $25.48 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $24.88 | 2019 | |
| Mission Pharmacal Company | $24.69 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $21.40 | 2023 | Injectafer |
| Allergan, INC. | $19.44 | 2020 | |
| Phadia US INC. | $19.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $18.44 | 2020 | |
| Qiagen, LLC | $13.82 | 2020 | |
| Hologic Sales and Service, LLC | $13.34 | 2021 | |
| Genentech USA, INC. | $13.30 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.81 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.58 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $7.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Lowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.